Literature DB >> 7542298

Direct and indirect control of T-cell activation by keratinocytes.

B J Nickoloff1, L A Turka, R S Mitra, F O Nestle.   

Abstract

Keratinocytes can function as antigen-presenting cells/accessory cells and regulate T cells with three distinct outcomes, depending on the nature of the stimulus. In the presence of alloantigen, it appears that a "null" event takes place between T cells and keratinocytes, with neither activation nor induction of tolerance. Using nominal antigen, keratinocytes induce antigen-specific tolerance. In contrast, with bacterial-derived superantigens, phytohemagglutinin, or immobilized CD3 monoclonal antibody, keratinocytes can significantly activate resting autologous T-cell proliferation and cytokine release. To understand these highly divergent responses, we focused on the two-signal model of T-cell activation, with particular emphasis on costimulatory molecules expressed by keratinocytes. Such second signals, as highlighted by the B7 and CD28 receptor families, provide useful insights into the complex interactions involving keratinocytes and T cells. In this review, we summarize recent evidence indicating that keratinocytes regulate T-cell activation in a direct and indirect manner by their mutual expression and responsiveness involving adhesion molecules, cytokines, and costimulatory signals. As investigative momentum continues to grow in the fields of immunology and keratinocyte biology, it is likely that manipulation of CD28:B7 interactions will not only provide a useful model to understand further the complexities of skin immune reactions, but will also serve as the basis for new therapeutic opportunities for numerous T-cell-mediated diseases that involve aberrant reactions with keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542298     DOI: 10.1111/1523-1747.ep12315202

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation Device.

Authors:  Dinah H Amante; Trevor R F Smith; Janess M Mendoza; Katherine Schultheis; Jay R McCoy; Amir S Khan; Niranjan Y Sardesai; Kate E Broderick
Journal:  Hum Gene Ther Methods       Date:  2015-08       Impact factor: 2.396

2.  Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin.

Authors:  K Sugita; K Kabashima; K Atarashi; T Shimauchi; M Kobayashi; Y Tokura
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 3.  [Contact dermatitis. II].

Authors:  P J Frosch; T Rustemeyer; A Schnuch
Journal:  Hautarzt       Date:  1996-12       Impact factor: 0.751

4.  Severe papillomavirus infection progressing to metastatic squamous cell carcinoma in bone marrow-transplanted X-linked SCID dogs.

Authors:  Michael H Goldschmidt; Jeffrey S Kennedy; Douglas R Kennedy; Hang Yuan; David E Holt; Margret L Casal; Anne M Traas; Elizabeth A Mauldin; Peter F Moore; Paula S Henthorn; Brian J Hartnett; Kenneth I Weinberg; Richard Schlegel; Peter J Felsburg
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Genomewide scan in german families reveals evidence for a novel psoriasis-susceptibility locus on chromosome 19p13.

Authors:  Y A Lee; F Rüschendorf; C Windemuth; M Schmitt-Egenolf; A Stadelmann; G Nürnberg; M Ständer; T F Wienker; A Reis; H Traupe
Journal:  Am J Hum Genet       Date:  2000-09-13       Impact factor: 11.025

6.  Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis.

Authors:  J P Seery; J M Carroll; V Cattell; F M Watt
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

7.  Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.

Authors:  Janess M Mendoza; Dinah H Amante; Gleb Kichaev; Christine L Knott; William B Kiosses; Trevor R F Smith; Niranjan Y Sardesai; Kate E Broderick
Journal:  Vaccines (Basel)       Date:  2013-08-28

8.  Oral Administration of 4-Hydroxy-3-Methoxycinnamaldehyde Attenuates Atopic Dermatitis by Inhibiting T Cell and Keratinocyte Activation.

Authors:  Hyun-Su Lee; Eun-Ju Choi; Heeri Choi; Kyung-Sik Lee; Hye-Ran Kim; Bo-Ra Na; Min-Sung Kwon; Gil-Saeng Jeong; Hyun Gyu Choi; Eun Young Choi; Chang-Duk Jun
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.